Literature DB >> 31390443

Seroprevalence of Trypanosoma cruzi infection among blood donors in the state of Bahia, Brazil.

Diego Lopes Paim Miranda1,2, Gilmar Ribeiro2, Fernanda Cardoso Lanza2, Fred Luciano Neves Santos2, Renato Barbosa Reis2, Deborah Bittencourt Mothé Fraga2, Luciano Kalabric Silva2, Marinho Marques da Silva Neto3, Iraildes de Jesus Santana3, Mitermayer Galvão Dos Reis1,2,4.   

Abstract

INTRODUCTION: Chagas disease (CD) affects 5.7-7.0 million individuals worldwide, and its prevalence reached 25.1% in the state of Bahia, Brazil. There is an association between the prevalence of CD, the socioeconomic status of the population, and the risk of re-emergence due to non-vectorial transmission, such as blood transfusion. This study determined the seroprevalence of T. cruzi infection among blood donors in the state of Bahia, located in northeastern Brazil, and their epidemiological profile during a 10-year period.
METHODS: We performed a descriptive cross-sectional study involving a database review. Data were collected from patients with non-negative results for T. cruzi infection during a 10-year period.
RESULTS: A total of 3,084 (0.62%) samples were non-negative for T. cruzi infection in an initial serological screening, and 810 (0.16%) samples were non-negative in the second screening. The correlation between infection and age (30 years or older) and between infection and lower educational level (12 years or less) in the first and second screening was statistically significant. The seroprevalence of T. cruzi infection was higher in men in the first screening. In addition, 99.52% of the municipalities of Bahia had at least one case of CD. Livramento de Nossa Senhora and Salvador presented the highest disease prevalence and recurrence, respectively.
CONCLUSIONS: The seroprevalence of T. cruzi infection in these populations was lower than that found in other studies in Brazil but was comparatively higher in densely-populated areas. The demographic characteristics of our population agreed with previous studies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31390443     DOI: 10.1590/0037-8682-0146-2019

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

1.  Trends of Seroprevalence of Chagas´s diseases in healthy blood donors, solid organ donors and heart transplant recipients: experience of a single health care center in Colombia.

Authors:  María Elena Tello-Cajiao; Olga Lucia Agudelo; Marcela Quintero; Laura Cardenas; Fernando Rosso
Journal:  Epidemiol Infect       Date:  2020-11-06       Impact factor: 2.451

2.  Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens.

Authors:  Emily F Santos; Leonardo M Leony; Ângelo A O Silva; Ramona T Daltro; Natália E M Freitas; Larissa C M Vasconcelos; Fernando L V de Araújo; Paola A F Celedon; Marco A Krieger; Nilson I T Zanchin; Fred L N Santos
Journal:  Transfusion       Date:  2021-07-09       Impact factor: 3.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.